Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ly93

Copy Product Info
😃Good
Catalog No. T15822Cas No. 1883528-69-5

Ly93 is a selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor (IC50: 91 nM) used for studying atherosclerosis.

Ly93

Ly93

Copy Product Info
😃Good
Purity: 99.88%
Catalog No. T15822Cas No. 1883528-69-5
Ly93 is a selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor (IC50: 91 nM) used for studying atherosclerosis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$74-In Stock
5 mg$123-In Stock
10 mg$198-In Stock
25 mg$372-In Stock
50 mg$619-In Stock
100 mg$953-In Stock
200 mg$1,280-In Stock
1 mL x 10 mM (in DMSO)$135-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.88%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Ly93 is a selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor (IC50: 91 nM) used for studying atherosclerosis.
In vivo
Pharmacokinetic characterization of Ly93 conducted in C57BL/6J mice suggests oral efficacy of Ly93. As an effective selective SMS2 inhibitor, Ly93 (100 mg/kg, i.g. once daily for 7 days) significantly reduced plasma SM levels in C57BL/6J mice[1].
Chemical Properties
Molecular Weight332.4
FormulaC21H20N2O2
Cas No.1883528-69-5
SmilesCCc1ccccc1COc1ccccc1C(=O)Nc1cccnc1
Relative Density.1.191 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (240.67 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (9.93 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0084 mL15.0421 mL30.0842 mL150.4212 mL
5 mM0.6017 mL3.0084 mL6.0168 mL30.0842 mL
10 mM0.3008 mL1.5042 mL3.0084 mL15.0421 mL
20 mM0.1504 mL0.7521 mL1.5042 mL7.5211 mL
50 mM0.0602 mL0.3008 mL0.6017 mL3.0084 mL
100 mM0.0301 mL0.1504 mL0.3008 mL1.5042 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ly93 | purchase Ly93 | Ly93 cost | order Ly93 | Ly93 chemical structure | Ly93 in vivo | Ly93 formula | Ly93 molecular weight